yes, they get revenue from licenses and they still own rights to 2 drugs. Also heard that FDA waived millions owed in fees for the 2 drugs that the company still owns so that makes this stock at least a 5 bagger from here
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.